Trump’s new ‘ Most-Favored-Nation ’ drug pricing order just rewrote the rules of American pharma economics – and investors haven’t processed the aftershock yet.
Source link
A Silent Crash Inside S&P’s Good Day
Trump’s new ‘ Most-Favored-Nation ’ drug pricing order just rewrote the rules of American pharma economics – and investors haven’t processed the aftershock yet.
Source link